Current status and progress of surgical treatment of knee cartilage repair

doi:10.3877/cma.j.issn.1674-134X.2022.02.012

Abstract

Abstract:

Knee cartilage is composed of chondrocytes and the surrounding extracellular matrix, which is an important part of joint formation and maintenance of joint function. Knee cartilage is a kind of tissue without blood vessel and nerve. Once injured, its self-healing ability is limited. However, cartilage damage in the knee joint is very common, occurring in more than 60% of arthroscopic knee surgeries.There may be no clinically relevant symptoms in the early stage of knee cartilage injury, but pain and swelling may appear after symptoms, and then develop into osteoarthritis, joint stiffness, and even disability. At present, it is still a challenge for clinicians to have a good long-term curative effect in the surgical treatment of knee cartilage injury. This article reviewed the current situation and progress of surgical treatment of knee cartilage repair.

Key words: Knee joint, Cartilage, articular, Surgical procedures, operative, Therapeutics

Xiaoyu Lyu, Ming Wang, Zhian Chen, Yujiao Feng, Libo Yuan, Rongmao Shi, Yongqing Xu, Hongbo Tan. Current status and progress of surgical treatment of knee cartilage repair[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2022, 16(02): 213-218.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgjwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-134X.2022.02.012

https://zhgjwkzz.cma-cmc.com.cn/EN/Y2022/V16/I02/213

References 42

[1]	Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25，124 knee arthroscopies[J]. Knee, 2007, 14(3): 177-82.
[2]	Arøen A, Løken S, Heir S, et al. Articular cartilage lesions in 993 consecutive knee arthroscopies[J]. Am J Sports Med, 2004, 32(1): 211-215.
[3]	Heir S, Nerhus TK, Røtterud JH, et al. Focal cartilage defects in the knee impair quality of life as much as severe osteoarthritis: a comparison of knee injury and osteoarthritis outcome score in 4 patient categories scheduled for knee surgery[J]. Am J Sports Med, 2010, 38(2): 231-237.
[4]	Davies RL, Kuiper NJ. Regenerative Medicine: a review of the evolution of autologous chondrocyte Implantation (ACI) therapy[J/OL]. Bioengineering (Basel), 2019, 6(1). DOI：10.3390/bioengineering6010022.
[5]	Lee WY, Wang B. Cartilage repair by mesenchymal stem cells: clinical trial update and perspectives[J]. J Orthop Translat, 2017, 9: 76-88. DOI: 10.1016/j.jot.2017.03.005.
[6]	Gersing AS, Schwaiger BJ, Nevitt MC, et al. Weight loss regimen in obese and overweight individuals is associated with reduced cartilage degeneration: 96-month data from the osteoarthritis initiative[J]. Osteoarthritis Cartilage, 2019, 27(6): 863-870.
[7]	Migliore A, Procopio S. Effectiveness and utility of hyaluronic acid in osteoarthritis[J]. Clin Cases Miner Bone Metab, 2015, 12(1): 31-33.
[8]	Merkely G, Ogura T, Ackermann J, et al. Clinical outcomes after revision of autologous chondrocyte implantation to osteochondral allograft transplantation for large chondral defects: a comparative matched-group analysis[J]. Cartilage, 2021, 12(2): 155-161.
[9]	Solheim E, Hegna J, Inderhaug E. Early determinants of long-term clinical outcome after cartilage repair surgery in the knee[J]. J Orthop, 2018, 15(1): 222-225.
[10]	Rodriguez-Merchan EC, Valentino LA. The role of gene therapy in cartilage repair[J]. Arch Bone Jt Surg, 2019, 7(2): 79-90.
[11]	Laupattarakasem W, Laopaiboon M, Laupattarakasem P, et al. Arthroscopic debridement for knee osteoarthritis[J/OL]. Cochrane Database Syst Rev, 2008(1): Cd005118. DOI: 10.1002/14651858.CD005118.pub2.
[12]	Scillia AJ, Aune KT, Andrachuk JS, et al. Return to play after chondroplasty of the knee in National Football League athletes[J]. Am J Sports Med, 2015, 43(3): 663-668.
[13]	Weiβenberger M, Heinz T, Boelch SP, et al. Is debridement beneficial for focal cartilage defects of the knee: data from the German Cartilage Registry (KnorpelRegister DGOU)[J]. Arch Orthop Trauma Surg, 2020, 140(3): 373-382.
[14]	Redondo ML, Beer AJ, Yanke AB. Cartilage restoration: microfracture and osteochondral autograft transplantation[J]. J Knee Surg, 2018, 31(3): 231-238.
[15]	Orth P, Gao L, Madry H. Microfracture for cartilage repair in the knee: a systematic review of the contemporary literature[J]. Knee Surg Sports Traumatol Arthrosc, 2020, 28(3): 670-706.
[16]	Mithoefer K, Mcadams T, Williams R J, et al. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis[J]. Am J Sports Med, 2009, 37(10): 2053-2063.
[17]	Cole BJ, Farr J, Winalski CS, et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up[J]. Am J Sports Med, 2011, 39(6): 1170-1179.
[18]	Benthien JP, Behrens P. Reviewing subchondral cartilage surgery: considerations for standardised and outcome predictable cartilage remodelling: a technical note[J]. Int Orthop, 2013, 37(11): 2139-2145.
[19]	Zedde P, Cudoni S, Giachetti G, et al. Subchondral bone remodeling: comparing nanofracture with microfracture. An ovine in vivo study[J]. Joints, 2016, 4(2): 87-93.
[20]	袁林，郭燕庆，于洪波，等. 富血小板血浆治疗Ⅱ-Ⅲ期膝骨关节炎的疗效评价[J/CD]. 中华关节外科杂志(电子版), 2016, 10(04): 386-392.
[21]	Koh YG, Kwon OR, Kim YS, et al. Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial[J]. Arthroscopy, 2016, 32(1): 97-109.
[22]	Madry H, Gao L, Eichler H, et al. Bone marrow aspirate concentrate-enhanced marrow stimulation of chondral defects[J/OL]. Stem Cells Int, 2017, 2017: 1609685. DOI：10.1155/2017/1609685.
[23]	Richter DL, Schenck RC, Jr., Wascher DC, et al. Knee articular cartilage repair and restoration techniques: a review of the literature[J]. Sports Health, 2016, 8(2): 153-160.
[24]	Gudas R, Gudaite A, Pocius A, et al. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes[J]. Am J Sports Med, 2012, 40(11): 2499-508.
[25]	Armiento AR, Stoddart MJ, Alini M, et al. Biomaterials for articular cartilage tissue engineering: learning from biology[J/OL]. Acta Biomater, 2018, 65: 1-20. DOI: 10.1016/j.actbio.2017.11.021.
[26]	Murphy RT, Pennock AT, Bugbee WD. Osteochondral allograft transplantation of the knee in the pediatric and adolescent population[J]. Am J Sports Med, 2014, 42(3): 635-640.
[27]	Gross A E, Shasha N, Aubin P. Long-term followup of the use of fresh osteochondral allografts for posttraumatic knee defects[J]. Clin Orthop Relat Res, 2005, (435): 79-87.
[28]	Moradi B, Schönit E, Nierhoff C, et al. First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years′ clinical and magnetic resonance imaging follow-up evaluation[J]. Arthroscopy, 2012, 28(12): 1851-1861.
[29]	Ebert JR, Edwards PK. The evolution of progressive postoperative weight bearing after autologous chondrocyte implantation in the tibiofemoral joint[J]. J Sport Rehabil, 2014, 23(3): 192-202.
[30]	Bonasia DE, Marmotti A, Rosso F, et al. Use of chondral fragments for one stage cartilage repair: a systematic review[J]. World J Orthop, 2015, 6(11): 1006-1011.
[31]	Bonasia DE, Martin JA, Marmotti A, et al. The use of autologous adult, allogenic juvenile, and combined juvenile-adult cartilage fragments for the repair of chondral defects[J]. Knee Surg Sports Traumatol Arthrosc, 2016, 24(12): 3988-3996.
[32]	Lee WS, Kim HJ, Kim KI, et al. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial[J]. Stem Cells Transl Med, 2019, 8(6): 504-511.
[33]	Huang BJ, Hu JC, Athanasiou A. Cell-based tissue engineering strategies used in the clinical repair of articular cartilage[J/OL]. Biomaterials, 2016, 98: 1-22. DOI：10.1016/j.biomaterials.2016.04.018.
[34]	Temenoff JS, Mikos AG. Review: tissue engineering for regeneration of articular cartilage[J]. Biomaterials, 2000, 21(5): 431-440.
[35]	Churchman SM, Boxall SA, McGonagle D, et al. Predicting the remaining lifespan and cultivation-related loss of osteogenic capacity of bone marrow multipotential stromal cells applicable across a broad donor age range[J/OL]. Stem Cells Int, 2017：10. DOI: 10.1155/2017/6129596.6129596.
[36]	Yang J, Zhang YS, Yue K, et al. Cell-laden hydrogels for osteochondral and cartilage tissue engineering[J/OL]. Acta Biomater, 2017, 57: 1-25. DOI: 10.1016/j.actbio.2017.01.036.
[37]	Li S, Glynne-Jones P, Andriotis OG, et al. Application of an acoustofluidic perfusion bioreactor for cartilage tissue engineering[J]. Lab Chip, 2014, 14(23): 4475-4485.
[38]	Shi S, Chan AG, Mercer S, et al. Endogenous versus exogenous growth factor regulation of articular chondrocytes[J]. J Orthop Res, 2014, 32(1): 54-60.
[39]	Bellavia D, Veronesi F, Carina V, et al. Gene therapy for chondral and osteochondral regeneration: is the future now？[J]. Cell Mol Life Sci, 2018, 75(4): 649-667.
[40]	Grol MW, Lee BH. Gene therapy for repair and regeneration of bone and cartilage[J]. Curr Opin Pharmacol, 2018, 40: 59-66.
[41]	Evans CH, Ghivizzani SC, Robbins PD. Gene delivery to joints by intra-articular injection[J]. Hum Gene Ther, 2018, 29(1): 2-14.
[42]	Kim MK, Ha CW, In Y, et al. A multicenter, double-blind, phase III clinical trial to evaluate the efficacy and safety of a cell and gene therapy in knee osteoarthritis patients[J]. Hum Gene Ther Clin Dev, 2018, 29(1): 48-59.

Please choose a citation manager

Content to export